Anika Therapeutics, Inc. (ANIK)
19.10
-0.26
(-1.34%)
USD |
NASDAQ |
Oct 02, 16:00
19.12
+0.02
(+0.10%)
After-Hours: 20:00
Anika Therapeutics Max Drawdown (5Y) : 83.15% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 83.15% |
| August 31, 2026 | 83.15% |
| July 31, 2026 | 83.15% |
| June 30, 2026 | 83.15% |
| May 31, 2026 | 83.15% |
| April 30, 2026 | 83.15% |
| March 31, 2026 | 83.15% |
| February 28, 2026 | 83.15% |
| January 31, 2026 | 83.15% |
| December 31, 2025 | 83.15% |
| November 30, 2025 | 83.15% |
| October 31, 2025 | 83.15% |
| September 30, 2025 | 83.15% |
| August 31, 2025 | 83.15% |
| July 31, 2025 | 83.15% |
| June 30, 2025 | 78.00% |
| May 31, 2025 | 76.87% |
| April 30, 2025 | 76.85% |
| March 31, 2025 | 76.85% |
| February 28, 2025 | 76.85% |
| January 31, 2025 | 76.85% |
| December 31, 2024 | 76.85% |
| November 30, 2024 | 76.85% |
| October 31, 2024 | 76.85% |
| September 30, 2024 | 76.85% |
| Date | Value |
|---|---|
| August 31, 2024 | 76.85% |
| July 31, 2024 | 76.85% |
| June 30, 2024 | 76.85% |
| May 31, 2024 | 76.85% |
| April 30, 2024 | 76.85% |
| March 31, 2024 | 76.85% |
| February 29, 2024 | 76.85% |
| January 31, 2024 | 76.85% |
| December 31, 2023 | 76.85% |
| November 30, 2023 | 76.85% |
| October 31, 2023 | 76.85% |
| September 30, 2023 | 76.85% |
| August 31, 2023 | 75.67% |
| July 31, 2023 | 72.19% |
| June 30, 2023 | 72.19% |
| May 31, 2023 | 72.19% |
| April 30, 2023 | 72.19% |
| March 31, 2023 | 72.19% |
| February 28, 2023 | 72.19% |
| January 31, 2023 | 72.19% |
| December 31, 2022 | 72.19% |
| November 30, 2022 | 72.19% |
| October 31, 2022 | 72.19% |
| September 30, 2022 | 72.19% |
| August 31, 2022 | 72.19% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Precigen, Inc. | 95.58% |
| Repligen Corp. | 68.27% |
| Amgen, Inc. | 24.86% |
| Biogen, Inc. | 72.66% |
| BioMarin Pharmaceutical, Inc. | 58.73% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -20.21 |
| Beta (5Y) | 0.2108 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 41.99% |
| Historical Sharpe Ratio (5Y) | -0.431 |
| Historical Sortino (5Y) | -0.6684 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.95% |